Floatz logo

11 assets in Chronic Hepatitis B Virus Infection

Therapeutic assets addressing Chronic Hepatitis B Virus Infection, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Entecavir
Chronic Hepatitis B Virus Infection
Beijing Continent Pharmaceutical Co, Ltd.P4BBB (74)
Tenofovir Alafenamide
Chronic Hepatitis B Virus Infection
Ningbo No.2 HospitalP4BB (69)
Tenofovir Disoproxil Fumarate
Chronic Hepatitis B Virus Infection
Ningbo No.2 HospitalP4BB (67)
Hydronidone
Chronic Hepatitis B Virus Infection
Beijing Continent Pharmaceutical Co, Ltd.P3BB (66)
Empagliflozin
Chronic Hepatitis B Virus Infection
The University of Hong KongP4BB (65)
Tenofovir
Chronic Hepatitis B Virus Infection
Zhongshan Hospital (Xiamen), Fudan UniversityP3B (60)
Tenofovir Amibufenamide
Chronic Hepatitis B Virus Infection
Ningbo No.2 HospitalP1CCC (50)
Pegylated-Interferon .Alfa. 2B (Peg-Ifn)
Chronic Hepatitis B Virus Infection
Ningbo No.2 HospitalEarly P1C (39)
Babaodan
Chronic Hepatitis B Virus Infection
Nanfang Hospital, Southern Medical UniversityN/AD (30)
Biejia-Ruangan Compound
Chronic Hepatitis B Virus Infection
Nanfang Hospital, Southern Medical UniversityN/AD (30)